Aortic wall stiffness as a side-effect of anti-cancer medication

References

• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944.
   PubMed Web of Science ®Google Scholar
• Nichols WW, O’Rourke MF, McDonald’s VC. Blood flow in arteries: theoretical, experimental and clinical principles. 6 ed. London: Hodder Arnold; 2011.
   Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am College Cardiol. 2010;55:1318–1327.
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. on behalf of the European network for non invasive investigation of large arteries. Abridged version of the expert consensus document on arterial stiffness. Artery Res. 2007;1:2–12.
   Google Scholar
• Husmann M, Jacomella V, et al. Markers of arterial stiffness in peripheral arterial disease. VASA Zeitschrift fur Gefasskrankheiten. 2015;44:341–348.
   PubMed Web of Science ®Google Scholar
• Avolio AP, Van Bortel LM, Boutouyrie P, et al. Role of pulse pressure amplification in arterial hypertension: experts’ opinion and review of the data. Hypertension. 2009 Aug;54(2):375–383.
   PubMed Web of Science ®Google Scholar
• Mattace-Raso F, Hofman A, Verwoert GC, et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Reference values for arterial stiffness’ collaboration. Eur Heart J. 2010 Oct;31(19):2338–2350.
   PubMed Web of Science ®Google Scholar
• Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American heart association. American heart association council on hypertension. Hypertension. 2015 Sep;66(3):698–722.
   PubMed Web of Science ®Google Scholar
• Zamorano JL, Lancellotti P,  Muñoz DR, et al. ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768–2801.
   PubMed Web of Science ®Google Scholar
• Vejpongsa P, Yeh ET. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol. 2014 Sep 2; 64(9):938–945.
   PubMed Web of Science ®Google Scholar
• Duquaine D, Hirsch G, Chakrabarti A, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med. 2003;8:101–107.
   PubMed Web of Science ®Google Scholar
• Jenei Z, Bárdi E, Magyar MT, et al. Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer. Pathol Oncol Res. 2013 Jul;19(3):375–383.
   PubMed Web of Science ®Google Scholar
• Chaosuwannakit N, Ralph D’Agostino CA, Hamilton, et al. Aortic stiffness increases upon receipt of anthracycline chemotherapy. Clin Oncol. 2010 Jan 1;28(1):166–172.
   Web of Science ®Google Scholar
• Chaosuwannakit N, D’Agostino R Jr, Hamilton CA, et al. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol. 2010;28(1):166–172.
   PubMed Web of Science ®Google Scholar
• Budinskaya K, Puchnerová V, Svačinová J, et al. Non-invasive assessment of vascular system function and damage induced by anthracycline treatment in the pediatric cancer survivors. Physiol Res. 2017 Dec;30(Supplementum 4):S553–S560.
   Google Scholar
• Drafts BC, Twomley KM, D’Agostino R Jr, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877–885.
   PubMed Web of Science ®Google Scholar
• Vogelzang NJ, Frenning DH, Kennedy BJ. Coronary artery disease after treatment with bleomycin and vinblastine. Cancer Treat Rep. 1980;64:1159–1160.
   PubMedGoogle Scholar
• Doll DC, List AF, Greco FA, et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med. 1986;105:48–51.
   PubMed Web of Science ®Google Scholar
• Sekijima T, Tanabe A, Maruoka R, et al. Impact of platinum-based chemotherapy on the progression of atherosclerosis. Climacteric. 2011 Feb;14(1):31–40.
   PubMed Web of Science ®Google Scholar
• Stelwagen J, Lubberts S,  Steggink LC, et al. Vascular damage and pulmonary function in very long-term survivors of testicular cancer (TC) treated with cisplatin-based chemotherapy (CT). Ann Oncol. 2018;29:suppl_8:viii303–viii331.
   Google Scholar
• Mozos I, Borzak G, Caraba A, et al. Arterial stiffness in hematologic malignancies. Onco Targets Ther. 2017 Mar 3;10:1381–1388.
   PubMed Web of Science ®Google Scholar
• Koelwyn GJ, Lewis NC, Ellard SL, et al. Ventricular-arterial coupling in breast cancer patients after treatment with anthracycline-containing adjuvant chemotherapy. Oncologist. 2016;21(2):141–149.
   PubMed Web of Science ®Google Scholar
• SOUZA CA, Simões R, Borges KBG. et al. Arterial stiffness use for early monitoring of cardiovascular adverse events due to anthracycline chemotherapy in breast cancer patients. A pilot study. Arq Bras Cardiol. 2018;111(5):721–728.
   PubMed Web of Science ®Google Scholar
• Blaes AH, Mulrooney DA, Vogel RI, et al. Joseph Philip NegliaDaniel Duprez Arterial elasticity in testicular cancer survivors University of Minnesota, Minneapolis. J Clin Oncol. 2014;32:9604.
   Web of Science ®Google Scholar
• Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Herceptin adjuvant (HERA) trial study team. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659–1672.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Bono P, Kataja V, et al. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial. J Clin Oncol. 2009;27(34):5685–5692.
   PubMed Web of Science ®Google Scholar
• Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER-2-positive breast cancer. N Engl J Med. 2005;35(16):1673.
   Google Scholar
• Ö Y, Eryilmaz U, Akdam H, et al. Arterial stiffness in breast cancer patients treated with anthracycline and trastuzumab-based regimens. Cardiol Res Pract. 2018 May;2018:5352914.
   PubMed Web of Science ®Google Scholar
• Grover S, Lou PW, Bradbrook C, et al. Early and late changes in markers of aortic stiffness with breast cancer therapy. Intern Med J. 2015 Feb;45(2):140–147.
   PubMed Web of Science ®Google Scholar
• Filatova AY, Vitsenya MV, Potekhina AV, et al. Atherosclerosis of brachiocephalic arteries and arterial stiffness in patients with breast cancer. Kardiologiia. 2019 Jan 31;59(1S):43–52.
   PubMedGoogle Scholar
• Res E, Kyvelou SM, Vlachopoulos C, et al. Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy. Onco Targets Ther. 2018 Oct;11(11):6785–6793.
   PubMedGoogle Scholar
• Vlachopoulos C, Gravos A, Georgiopoulos G, et al. The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis. Clin Rheumatol. 2018 Feb;37(2):515–526.
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Gravos A, Vlachopoulos C, et al. Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis. Clin Rheumatol. 2015 Feb;34(2):359–364.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, CANTOS Trial Group et al. . Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017 Sep;21(12):1119–1131.
   Google Scholar
• Valent P, Hadzijusufovic E, Schernthaner GH, et al. Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors. Blood. 2015;125(6):901–906.
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Wintersperger BJ, Flamm SD, et al. cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy. A systematic review. Circ Cardiovasc Imaging. 2013;6(6):1080–1091.
   PubMed Web of Science ®Google Scholar
• Larson RA, Hochhaus A, Hughes TP, et al. Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: eNESTnd 3-year follow-up. Leukemia. 2012;26(10):2197–2203.
   PubMed Web of Science ®Google Scholar
• Kim TD, Rea D, Schwarz M, et al. Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib. Leukemia. 2013 Jun;27(6):1316–1321.
   PubMed Web of Science ®Google Scholar
• Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109:3122–3131.
   PubMed Web of Science ®Google Scholar
• Schimmel KJ, Richel DJ, van Den Brink RB, et al. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004;30:181–191.
   PubMed Web of Science ®Google Scholar
• Khakoo AY, Liu PP, Force T, et al. Cardiotoxicity due to cancer therapy. Tex Heart Inst J. 2011;38:253–256.
   PubMed Web of Science ®Google Scholar
• Alter P, Herzum M, Soufi M, et al. Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem. 2006;4:1–5.
   PubMedGoogle Scholar
• Mozos I, Mihaescu R. Pulse wave velocity and central hemodynamic indices in patients with malignant solid tumors. Jokull. 2006;65:200–214.
   Google Scholar
• Richard JW, Baghdadi LR, Shanahan ME, et al. The temporal relationship between arterial stiffening and blood pressure is modified by methotrexate treatment in patients with rheumatoid arthritis. 2017;8:593.
   Google Scholar
• Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (ARTERY) society. Atherosclerosis. 2015 Aug;241(2):507–532.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Colombo A, Sandri MT, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006 Dec 5;114(23):2474–2481.
   PubMed Web of Science ®Google Scholar
• Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012 Mar;221(1):18–33.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Georgakopoulos C, Pietri P, et al. Effect of ticagrelor versus clopidogrel on aortic stiffness in patients with coronary artery disease. J Am Heart Assoc. 2019 Jun 18;8(12):e012521.
   PubMed Web of Science ®Google Scholar
• Pietri P, Vlachopoulos C, Terentes-Printzios D, et al. Beneficial effects of low-dose aspirin on aortic stiffness in hypertensive patients. Vasc Med. 2014 Dec;19(6):452–457.
   PubMed Web of Science ®Google Scholar
• Cappetta D, Esposito G, Coppini R. Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction. Br J Pharmacol. 2017 Nov;174(21):3696–3712.
   PubMed Web of Science ®Google Scholar
• Corradi F, Paolini L, De Caterina R. Ranolazine in the prevention of anthracycline cardiotoxicity. Pharmacol Res. 2014 Jan;79:88–102.
   PubMed Web of Science ®Google Scholar
• Madden KM, MD CL, Darcye Cuff PHD, et al. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care. 2009 Aug;32(8):1531–1535.
   Google Scholar
• Tabara Y, Yuasa T, Oshiumi A, et al. Effect of acute and long-term aerobic exercise on arterial stiffness in the elderly. Hypertens Res. 2007 Oct;30(10):895–902.
   PubMed Web of Science ®Google Scholar
• Joseph JC, Wu P-T, Holly R, et al. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions. Am J Physiol. 2017;312(2):H213-H222.
   Google Scholar
• Cheitlin MD, Armstrong WF, Aurigemma GP, et al.; ACC/AHA/ASE 2003. Guideline update for the clinical application of echocardiography: summary article. A report of the American College Of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Soc Echocardiogr. 2003;16:1091–1110.
   PubMed Web of Science ®Google Scholar
• American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011. Appropriate use criteria for echocardiography. A report of the American college of cardiology foundation appropriate use criteria task force, American society of echocardiography, American heart association, American society of nuclear cardiology, heart failure society of America, Heart rhythm society, society for cardiovascular angiography and interventions, Society of critical care medicine, Society of cardiovascular computed tomography, Society for cardiovascular magnetic resonance American college of chest physicians. J Am Soc Echocardiogr. 2011;24:229–267.
   PubMedGoogle Scholar
• Calabia J, Torguet P, Garcia M, et al. Doppler ultrasound in the measurement of pulse wave velocity: agreement with the complior method. Cardiovascular Ultrasound. 2011 April; 9:13.
   Google Scholar
• Reshetnik A, Gohlisch C, Tölle M, et al. Oscillometric assessment of arterial stiffness in everyday clinical practice. Hypertens Res. 2017 Feb;40(2):140–145.
   PubMed Web of Science ®Google Scholar
• Thom T, Haase N, Rosamond W, et al. American heart association. Heart disease and stroke statistics—2006 update. Circulation. 2006 Jan;113:e85–e151.
   Google Scholar
• Ries L, Eisner M, Kosary C, et al. SEER cancer statistics review. Bethesda, Md: US National Cancer Institute 1975–2000; 2003.
   Google Scholar
• Hogan P, Dall T, Nikolov P, the American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–932.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health, National Heart, Lung, and Blood Institute. Fact book fiscal year 2003. Bethesda, Md: National Institutes of Health; 2004.
   Google Scholar
• Nanoudis S, Pikilidou M, Yavropoulou M, et al. The role of microRNAs in arterial stiffness and arterial calcification. An update and review of the literature. Front Genet. 2017 Dec 12;8:209.
   PubMed Web of Science ®Google Scholar
• McKenney-Drake ML, Moghbel MC, Paydary K, et al. 18F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging; 2018 Jul 6 ;45(12):2190–2200.
   PubMed Web of Science ®Google Scholar
• Toutouzas K, Koutagiar I, Benetos G, et al. Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study. Eur Heart J Cardiovasc Imaging. 2017 Nov 1;18(11):1236–1244.
   PubMed Web of Science ®Google Scholar
• Stefanie ADB, Heerspink HJ, Joop DL, et al. Linagliptin reduces arterial stiffness and arterial inflammation in persons with early type 2 diabetes: a Double-blind, randomized controlled trial. Circulation. 2016 Mar;134(29):A12647.
   Google Scholar